Home
>
National Drug Code (NDC)
>
Maxiphen
Maxiphen - 58605-422-01 - (GUAIFENESIN and Phenylephrine Hydrochloride)
Drug Information of Maxiphen
| Product NDC: | 58605-422 |
| Proprietary Name: | Maxiphen |
| Non Proprietary Name: | GUAIFENESIN and Phenylephrine Hydrochloride |
| Active Ingredient(s): | 400; 10 mg/1; mg/1 & nbsp; GUAIFENESIN and Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Maxiphen
| Product NDC: | 58605-422 |
| Labeler Name: | MCR American Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20080331 |
Package Information of Maxiphen
| Package NDC: | 58605-422-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (58605-422-01) |
NDC Information of Maxiphen
| NDC Code | 58605-422-01 |
| Proprietary Name | Maxiphen |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (58605-422-01) |
| Product NDC | 58605-422 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | GUAIFENESIN and Phenylephrine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080331 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | MCR American Pharmaceuticals, Inc. |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 400; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |
